Nanomedicine & Drug Delivery Symposium (NanoDDS 2025)

Nanomedicine & Drug Delivery Symposium (NanoDDS 2025) will take place on October 27–28, 2025, at the Houston Methodist Research Institute in the Texas Medical Center, Houston, Texas and is co-chaired this year by Dr. Biana Godin, Dr. Francesca Taraballi and Dr. Alessandro Grattoni. NanoDDS is the first and one of the most important conferences in nanomedicine. Established over twenty years ago by Drs. Kabanov and Kataoka, it continues to be a premier forum for showcasing cutting-edge research and emerging technologies in drug delivery systems.

Building on its strong legacy, NanoDDS 2025 will bring together a multidisciplinary community of global experts, scientists, clinicians, and industry partners to foster collaboration and highlight the significant advancements in nanomedicine and drug delivery systems. This conference follows Houston Methodist’s tradition of hosting prestigious, highly visible symposia.

The objectives of the Nanomedicine and Drug Delivery Symposium are to discuss groundbreaking discoveries and developments in nanomedicine and drug/nucleic acid delivery; highlight clinical developments and opportunities for advancing nanomedicine technology to the marketplace; and engage and educate students, postdoctoral trainees and scientists locally, nationally and globally.

Co-sponsored by The George and Angelina Kostas Research Center for Cardiovascular Nanomedicine 

Celebrating the Impact of Nanoscience and Nanotechnology! 

The Nano Summit is MIT.nano's flagship conference, showcasing groundbreaking advancements in nanoscience and nanotechnology. The conference is ideal for researchers, industry professionals, entrepreneurs, and students interested in the latest developments in cutting-edge research, emerging technologies, and real-world applications.

The potential of AI to transform health care — through the work of both organizational leaders and medical professionals — is increasingly evident as more real-world clinical applications emerge.

In this accessible and clinician-focused tutorial, MIT Professor Regina Barzilay introduces the fundamentals of generative AI and its transformative applications in healthcare. Designed for healthcare professionals with no prior technical background, this session breaks down how models like ChatGPT and other large language models (LLMs) work, what they can (and can’t) do, and how they are already being used in clinical practice, from drafting patient notes to supporting clinical decision-making.

Participants will learn:

• Core concepts behind generative AI and LLMs

• Examples of real-world use cases in clinical settings

• Opportunities and limitations of these tools in daily practice

• How to critically evaluate AI-generated output

• Ethical considerations and potential challenges in medical applications

Whether you're curious about AI's potential or looking to responsibly integrate it into your work, this session offers a practical, clinician-oriented overview to help you engage with these emerging tools confidently and thoughtfully.

Time & Location

Sep 22, 2025, 8:00 AM – 9:00 AM

Cambridge, 50 Memorial Dr, Cambridge, MA 02142, USA

AI has transformed many areas of life in the last decade, yet the impact of these technologies on patient care is still limited. Building on the combined expertise of MIT and MGB in AI and clinical practice, the MIT-MGB AI Cures Conference showcases ongoing collaborative projects in clinical AI, highlighting cutting-edge research and their impact on patient care. Equally important is the process for collecting the data required to train clinical AI algorithms, with a focus on privacy, diversity, and quality. Our sincere hope is that this conference will help foster new MIT-MGB collaborations and inform the public about our collective efforts to improve patient care.

2025 Agenda

8:00AM

Pre-Conference Tutorial: Intro to Generative AI for Healthcare

Subject to fee | Register now 

Regina Barzilay (MIT)

8:30AM

Breakfast & Check-In

9:00AM

Opening Remarks

Sally Kornbluth, President (MIT)

Anne Klibanski, CEO and President (MGB)

9:15AM

Keynote​

John Halamka, President (Mayo Clinic Platform)

10:00AM

Break​

10:15AM

Session I: How Can AI Transform Healthcare? Real-World Examples 

Natalia Rost (MGB)

Bharti Khurana (MGB)

Elazer Edelman (MIT)

Dina Katabi (MIT)

11:15AM

Playbook for Implementing AI in Clinical Care (SYBIL)

Lecia Sequist, Workshop Chair (MGB)

Raymond Osarogiagbon (Baptist Memorial Healthcare)

William Mayfield (WellStar Health System)

Mary Pasquinelli (UI Health)

12:15PM

Lunch & Poster Presentations​
 

1:20PM

Optimizing AI Development with Data and Intellectual Sharing

Shawn Murphy (MGB)

1:25PM

RFP Announcement & Closing Remarks

Paul Anderson (MGB)

Regina Barzilay (MIT)

Please visit the following page for the most up-to-date information: https://www.nanomedicine.mit.edu/bioxai2025

Join fellow life science, computer science, engineering, and medical grad students and postdocs for a cross-school, cross discipline evening of BIOxAI community and informal pitch sharing hosted by MIT Hacking Medicine, the MIT Koch Institute, and the MIT Computer Science & Artificial Intelligence Lab. 

Pitch your research or startup idea, meet with NSF and industry startup supporters, talk to founders about their lab to market journey, and learn about resources to help you get started and funded – or just come and pitch yourself as a candidate to join a team or serve as a co-founder. Then stay for the reception and dinner. 

This is the event for you if you are interested in:

• Learning about BIOxAI research to startup pathways

• Pitching your BIOxAI idea or yourself (max 2 min)

• Recruiting high impact team members or a co-founder

• Joining an informal cross-discipline reception

Attendance is limited with a preference for those pitching their AIxBIO ideas, startups, team needs, or themselves.

Please apply if you are interested in attending, pitching, or both! Applications will close at 5 PM on September 10th, 2025.

This is the second edition of the Brookline Ave BIO Meetup. At the first meetup, we had about 100 people - a good mix of academics and industry folks and everyone from grad students to CEOs. We had a nice showing from the local Fenway biotech and investor crowd and people from all over the Longwood Medical Area (BIDMC, HMS, DFCI, BCH, Joslin, Wyss, BU, and BWH).

​​Come out to talk about science, medicine, business, entrepreneurship, collaboration, and the like. This is an informal event so just show up and introduce yourself. I'll likely have name tags but no other official programming.

​The event is not sponsored - you are responsible for buying your own drinks and you can get food from Time Out if you like.

​​Target Audience:

• ​​Academic researchers and clinicians

• ​​Biopharma

• ​​Tech Transfer

• ​​Investors, lawyers, business people

• ​​Anyone interested in commercializing science or related topics

Faculty Job Search Series: STEM Research Statements Faculty Panel

By Career Advising & Professional Development (CAPD)

What makes a STEM research statement successful? Hear from recent MIT alumni and current MIT faculty about their experiences writing research statements and/or evaluating them as members of a search committee. Get an expert perspective on mistakes to avoid, where to focus, and what you can leave out. For those on the faculty job search, this panel will be particularly useful as you prepare and refine your application materials. Open to MIT graduate students, postdocs and alumni.

Registration for this event is required via Handshake.

The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and developmental progress towards clinical and commercial approval.

To shine light on emerging areas and the latest progress, the 5th mRNA-Based Therapeutics Summit returns to Boston as the world's largest, end-to-end mRNA conference, gathering 320+ global stakeholders, sharing exclusive scientific and strategic insights from the biggest and newest players in the mRNA, Circular RNA & Self-Amplifying RNA fields including Moderna, Pfizer, BioNTech, Grann Pharmaceuticals, Celestial Therapeutics, Byterna Therapeutics and more.

Discover the realms of new infectious disease platforms, combating oncological targets and cell therapies across 4 dedicated tracks of content in Discovery, Pre-Clinical Development, Clinical Development and, Manufacturing & CMC as your one-stop-shop scientific content and partnering forum to aid the progress of pipelines in 2025 towards the clinic and ultimately patients in need.

Neuroblox Invited Talks & Discussions: New Ideas in Translational Neuroscience

Building 32, 141

32 VASSAR ST, Cambridge, MA 02139

9:00 am

Michael Breakspear, M.D. Ph.D. 

Neural field models suggest shared dynamics in brain and generative AI

10:00 am

Dost Öngür, M.D. Ph.D.

Current status of methods for examining the impact of pharmacologic interventions on brain function

11:00 am

Doug Rothman, Ph.D.

Towards developing a combined metabolic/neurotransmitter model for understanding the relationship between glutamate and GABA neurotransmitter fluxes and neuromodulator dopamine activity

12:00 pm

Michael J Frank, Ph.D.

Linking levels of analysis from brain to behavior in computational modeling

Antibody Drug Conjugates: Targeted Cancer Therapies at the Intersection of Chemistry, Biology, and Engineering

The 23rd Annual Koch Institute Symposium on Antibody Drug Conjugates: Targeted Cancer Therapies at the Intersection of Chemistry, Biology, and Engineering will take place on Friday, June 27, 2025. We cordially invite scientists, oncologists, and any other member of the biomedical community to join us in a day of engaging talks, stimulating conversations with colleagues, and of course camaraderie in our collective fight against cancer. 

Agenda

9:00 a.m. - 9:10 a.m. Opening remarks

Matthew Vander Heiden 
Director, MIT Koch Institute 

9:10 a.m. – 10:00 a.m. Keynote 

Introduction: Jessica Stark, MIT Koch Institute 

Carolyn Bertozzi 
Stanford University 
Topic: Antibody drug conjugate biological chemistry  

10:00 a.m. – 12:00 pmSession One  

Peter Senter
Pfizer
Topic: Antibody drug conjugate history 

Gerold Meinhardt
Daiichi Sankyo
Topic: Enhertu

Alison Betts
Takeda Pharmaceuticals
Topic: Antibody drug conjugate quantitative systems pharmacology 

Tim Lowinger
Mersana Therapeutics
Topic: Immunostimulatory antibody drug conjugates  

12:00 p.m. – 1:30 p.m.Lunch Break

1:30 p.m. – 2:30 p.m.Session Two: Short Presentations

Laurie Boyer
MIT Koch Institute
Topic: Lysosome morphology as predictor of drug efficacy

Dane Wittrup
MIT Koch Institute
Topic: Noncovalent capture antibody drug conjugates  

Jeremiah Johnson
MIT Koch Institute
Topic: Antibody-polymer conjugates 

Dasa Lipovsek
Aktis Oncology
Topic: Radioligand therapy 

2:30 p.m. – 4:30 p.m.Session Three  

Greg Thurber
University of Michigan
Topic: Strategies for uniform antibody drug conjugate penetration 

Puja Sapra
AstraZeneca
Topic: Antibody drug conjugate payloads and linker chemistry 

2025 Marble Center poster symposium

Tuesday May 20th , Luria Auditorium

The poster symposium will convene members of the Koch Institute for Integrative Cancer Research and broader MIT community working on nano- and precision based approaches for the early detection and treatment of cancer. The event will be held at the Koch Institute Luria Auditorium on May 20, 3:30-5:30pm. This will be an in-person only event, and will be an excellent opportunity to highlight collaborative projects in this area and get feedback from faculty and industry members.

Rebecca Stone has been selected as the recipient of the 2025 Judith Ann Lippard Memorial Lectureship. She will present her lecture, The Science Fiction of Ovarian Cancer: What We Got Wrong--and Why It Matters, to the MIT and Koch Institute communities in the Luria Auditorium (76-156) on Thursday, April 10, 2025 at 12:00-1:30 p.m.

Dr. Stone is associate professor and director of gynecologic oncology for Johns Hopkins. She holds a joint appointment in the Armstrong Institute as the lead for its surgical pathways/enhanced recovery after surgery program - an innovative, multidisciplinary program that standardizes perioperative care to improve quality and cost for thousands of patients annually. Dr. Stone also serves as co-director of the Fertility Preservation Center, pioneering novel surgical interventions to help people fulfill their goals of parenthood in the face of cancer. Accordingly, her research portfolio spans clinical, quality improvement, and basic science investigation.  She has been recognized for her dedication to patient care and teaching over the years, including being named Physician of the Year at Johns Hopkins in 2023 and being inducted into the School of Medicine Distinguished Teaching Society in 2022. Besides continuing to care for many patients and their families - this is her first love - she is devoted to ensuring that ovarian cancer prevention becomes a standard of care that all know about and can choose. Dr. Stone champions this mission in the U.S. with support from the Break Through Cancer and Gray Foundations and helps lead an international taskforce to decrease the global burden of ovarian cancer through prevention.

Harnessing biological insights to advance cancer nanomedicine

Joelle Straehla, MD

Seattle Children's Hospital

Dr. Joelle Straehla (formerly Hammond Lab and Koch Institute Clinical Investigator) will be giving a talk at the upcoming "Doctor is Leaving" Seminar on Tuesday April 8 from 12-1PM in Luria Auditorium. Joelle is a pediatric hematologist/oncologist and recently completed her tenure in the Clinical Investigator Program at the Koch Institute before moving her laboratory to Seattle Children's Hospital in the fall of 2024. She will be returning from Seattle to share the progress from her group while at MIT and exciting next steps in her talk entitled "Harnessing biological insights to advance cancer nanomedicine".

Join us at MIT’s Koch Institute for a celebration of the winners of the 2025 Image Awards—and their spectacular images of life sciences and biomedical research from across the Institute.

The reception will feature puzzles and a chance to mingle with the 2025 winning image creators.

5:00 p.m. Doors open and Unveiling Images
5:30 p.m. Award ceremony and lightning talks with image creators in Luria Auditorium
7:00 p.m. Reception in the KI Public Galleries

Can't attend in person? Register to attend the award ceremony on Zoom.

KI Oncology Seminar Series

New Therapeutic Strategies for Cancer Immunotherapy

TUESDAY, February 4, 2025

12:00 p.m. – 1:00 p.m.

Luria Auditorium, 76-156

James Moon, PhD

University of Michigan

The Moon Lab at the University of Michigan is developing new immunotherapies and vaccines at the interface of immunology, pharmaceutics, and engineering. We design new drug delivery systems for improving immune functions in the context of cancer, autoimmune diseases, and the gut microbiome. Our translational immunoengineering research utilizes tools of nanotechnology, biomaterials, drug delivery, tissue engineering, and advanced high-throughput methods to detect and improve immune functions.

30 Jan 2025 2:30 PM - 6:30 PM EST

Samberg Conference Center

MIT, Chang Building (E52), 50 Memorial Drive

Cambridge, MA

REGISTER

Morrison Foerster is proud to present MoForum 2025 | Life Sciences – Women of Impact, a premier event celebrating the contributions and achievements of women in life sciences. This unique program will spotlight female entrepreneurs, leaders, scientists, and investors who are shaping the future of the industry.

Gain inspiration and insights as our distinguished speakers share their stories of success, career journeys, and perspectives on navigating and thriving in the ever-evolving life sciences market.

We are delighted to feature influential voices from across the life sciences ecosystem, including:

• Yvonne Hao, Secretary of Economic Development for the Commonwealth of Massachusetts

• Padmini Pillai, White House Fellow

• Florence Bourgeois, Co-Director of the Harvard-MIT Center for Regulatory Science

• Adrienne Prentice, Founder, Keep Company

MoForum 2025 | Life Sciences – Women of Impact is tailored for professionals in the life sciences industry—including executives, policy makers, researchers, investors, and innovators—who are eager to connect, learn, and empower one another to drive meaningful change.

A detailed agenda will be available soon.

Please use the RSVP button above to register.

The AI, Health Equity, and Ethics Symposium explores the theme of epistemic humility, cultural humility, and diverse perspectives, alongside meaningful community involvement, to transform the way we think, learn, and collaborate to prevent AI from perpetuating existing disparities. Opening with a keynote by Dr. Tereza Hendl, a philosopher and bioethicist, the event explores broad ethical frameworks and specific challenges, such as the limitations of AI and bias. Workshops will focus on bias mitigation strategies co-designed with marginalized communities, emphasizing participatory action research to democratize innovation and promote just healthcare outcomes. By centering community expertise and lived experiences, the symposium encourages a reimagining of AI’s role in healthcare—ensuring that technological advances work to reduce, not reinforce, disparities.

Meet the Editor - Special Seminar

Wednesday, January 15, 2025 (12pm – 1pm )

Luria Audiorium 76-156

Montserrat Cols

Sr. Scientific Editor, Journal of Experimental Medicine

Montserrat (Montse) received her PhD from Keele University in the UK, working on molecular aspects of apoptosis of immune cells in fish. She then trained with Dr. Andrea Cerutti at Mount Sinai School of Medicine and more recently worked with Dr. Jayanta Chaudhuri at the Sloan Kettering Institute both in New York City. Throughout her training and appointments, her particular focus has been on many aspects relating to B cell biology, from inborn errors affecting human B-cell development and function to leukemia origin and development. Montse joined the Journal of Experimental Medicine (JEM) as a Scientific Editor in 2020 and was promoted to Senior Scientific Editor in 2022. Although an immunologist by training, Montse handles all types of studies at JEM, from microbial pathogenesis to stem cell biology and neuroscience.

The Convergence Scholars Program and the KI Postdoc Association are hosting a Panel Discussion with early-stage faculty on Tuesday, January 14, noon to 1:30pm.

The panelists will be Profs. Lindsay Case, Anders Hansen, Alison Ringel, and Francisco Sanchez-Rivera. Come and find out what it’s like to transition to a faculty position, set up a lab, and more!

The Human Tumor Atlas Network: Exploring tumor evolution in time and space

The much anticipated release of the latest collection of research and resources from the Human Tumor Atlas Network is now live.

Join us for a webinar in which leaders of HTAN, Li Ding (Washington University St Louis), Ken Lau (Vanderbilt University) and Shannon Hughes (US National Cancer Institute) discuss the latest exciting progress from HTAN. Chaired by Alexia-Ileana Zaromytidou (Chief Editor, Nature Cancer), the discussions will provide insight into HTAN’s collaborations to compile detailed atlases integrating cellular, molecular and histological features across diverse cancer types and stages. After their discussion, the speakers will be joined by HTAN research leader, Michael Snyder (Stanford University) to answer questions.

This webinar will explore:

• The history of HTAN

• The goals of assembling cancer atlases

• Functioning of a successful multi-institution consortium

• In numbers: HTAN’s scope and scale

• The power of spatial technologies

• Applying evolutionary principles in cancer research

• The importance of understanding the cancer microenvironment

• How you can use HTAN’s resources for your own research

• The future of the field

KI Oncology Seminar Series:

Josh Rabinowitz, PhD, Princeton University

Luria Auditorium

The Biomanufacturing Revolution in Historical Context

Robin Scheffler

Associate Professor

MIT Science, Technology, and Society

Location: 32-141

KI Oncology Seminar Series:

Scott Lowe, PhD, Memorial Sloan Kettering Cancer Center

Luria Auditorium

Russ Jenkins MD, PhD: Patient-derived organotypic spheroids to study immunotherapy response

Koch Institute Luria Auditorium

33rd Annual Irwin M. Arias Symposium

The first Irwin M. Arias, M.D. Symposium was held in 1991, and the theme of the event was – as it remains today – Bridging Basic Science and Liver Disease.

This unique one-day program brings together hundreds of leading biomedical scientists and physicians from across the globe and is designed to bridge the remarkable advances in basic biology and engineering with the understanding of liver diseases and their treatment. Research presented over the past 33 years has led to advances in the diagnosis and treatment of virtually all liver diseases in children and adults.

With plenary talks from renowned researchers and a collection of three-minute micro talks delivered by trainee scientists, the Arias Symposium is a model in ‘bridging’ between the academic, industrial, and clinical research communities – even across disciplines.

The 2024 symposium will be offered both in-person and virtually. In-person attendees will benefit from a poster session and networking opportunities with plenary speakers and other attendees. Breakfast, lunch, and a networking reception will also be provided to in-person attendees. Registration is free for all trainees (postdocs, fellows, grad. students, undergrads, etc.). Registration is $50 for in-person attendees other than trainees. Virtual attendance is free but requires registration.

We welcome participation from researchers at every stage of their careers, and invite them to share perspectives from their academic, industrial, and clinical research settings. Trainees and early-career investigators who are interested in presenting a micro-talk (in-person or virtually) or poster (in-person only) should submit an abstract with their registration. The deadline to submit an abstract is November 1, 2024.

For queries related to Arias Symposium corporate sponsorship, please contact Heidi Daniels, HDaniels@liverfoundation.org.